v2.4.0.8
Separation of AbbVie Inc. (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2014
AbbVie
   
Financial information for discontinued operations    
Term by which the transition services agreement can be extended   1 year
AbbVie | Maximum
   
Financial information for discontinued operations    
Term for which transition services may be provided   24 months
Proprietary Pharmaceuticals Business Assets and Liabilities Held for Disposal | AbbVie
   
Additional disclosures    
Trade accounts receivable $ 137 $ 137
Inventories 89 89
Equipment 16 16
Other assets 62 62
Trade accounts payable and accrued liabilities 242 242
Other liabilities 1 1
Obligation to transfer the net assets held for disposition included in other current liabilities 61 61
Proprietary Pharmaceuticals Business
   
Additional disclosures    
Earnings from discontinued operations, net tax benefits $ 6 $ 42